The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,6-Difluoro-3-((1-(4-butylphenyl)-5-oxo-4,5-dihydro-1H-pyrazol-3-yl)methoxy)benzamide ID: ALA4472740
Chembl Id: CHEMBL4472740
PubChem CID: 155535850
Max Phase: Preclinical
Molecular Formula: C21H21F2N3O3
Molecular Weight: 401.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCc1ccc(N2N=C(COc3ccc(F)c(C(N)=O)c3F)CC2=O)cc1
Standard InChI: InChI=1S/C21H21F2N3O3/c1-2-3-4-13-5-7-15(8-6-13)26-18(27)11-14(25-26)12-29-17-10-9-16(22)19(20(17)23)21(24)28/h5-10H,2-4,11-12H2,1H3,(H2,24,28)
Standard InChI Key: CYEMHXINKUJVLO-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 401.41Molecular Weight (Monoisotopic): 401.1551AlogP: 3.58#Rotatable Bonds: 8Polar Surface Area: 84.99Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: 10.96CX Basic pKa: CX LogP: 4.03CX LogD: 4.03Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.73Np Likeness Score: -1.00
References 1. Bi F, Song D, Qin Y, Liu X, Teng Y, Zhang N, Zhang P, Zhang N, Ma S.. (2019) Discovery of 1,3,4-oxadiazol-2-one-containing benzamide derivatives targeting FtsZ as highly potent agents of killing a variety of MDR bacteria strains., 27 (14): [PMID:31200986 ] [10.1016/j.bmc.2019.06.010 ]